NCT05119894 - A Clinical Pharmacology Trial of Brexpiprazole Long Acting Injectable (LAI) Administered as a Single Dose in Patients With Schizophrenia | Biotech Hunter

Timeline

Start Date

November 22, 2021

Primary Completion Date

December 6, 2021

Study Completion Date

December 6, 2021

Conditions

Schizophrenia

Interventions

DRUG

Brexpiprazole LAI: Dose 1

Cohort 1: Single Dose Intramuscular Injection: Brexpiprazole LAI Dose 1

DRUG

Brexpiprazole LAI: Dose 2

Cohort 2: Single Dose Intramuscular Injection:Brexpiprazole LAI Dose 2

DRUG

Brexpiprazole LAI: Dose 3

Cohort 3: Single Dose Intramuscular Injection:Brexpiprazole LAI Dose 3

DRUG

Brexpiprazole LAI: Dose 4

Cohort 4: Single Dose Intramuscular Injection:Brexpiprazole LAI Dose 4